Clinical Trials Logo

Filter by:
NCT ID: NCT03765333 Recruiting - Thyroid Cancer Clinical Trials

GETNE Registration of Thyroid Cancer

Start date: May 28, 2019
Phase:
Study type: Observational

An epidemiological, observational, multicenter, cross-sectional, retrospective study on patients ≥ 18 years visited in the oncology services of the participating centers with diagnosis of primary thyroid cancer.

NCT ID: NCT03765060 Recruiting - Clinical trials for Abdominal Wall Defect

The Efficacy and Security of the Small Stitch Technique in Emergency Surgery

STCU
Start date: October 1, 2018
Phase: N/A
Study type: Interventional

This study evaluates the abdominal closure technique in emergency surgery. Half of participants will be perform the classic Large Stitch technique, while the other half will undergo the Small Stitch technique.

NCT ID: NCT03764579 Recruiting - Childhood Obesity Clinical Trials

Dietary Habits and Sleep in Childhood Obesity

INFOB
Start date: November 29, 2018
Phase: N/A
Study type: Interventional

Recruitment of obese children, classification according to sleep questionnaire and randomization in two groups to perform nutritional and sleep intervention. . One group receives dietary intervention through recommendations. A group receives dietary and sleep intervention through recommendations. An analysis of the melatonin profile and metabolic and inflammatory status is performed by biochemistry at the beginning and end of the intervention. Determine if the intervention has improved the health of obese children.

NCT ID: NCT03764176 Recruiting - Clinical trials for Dental Implant Failure

Accuracy of Computer-assisted Template-based Implant Placement Using Conventional or Digital Impression

Start date: January 8, 2018
Phase: N/A
Study type: Interventional

Proper implant position has a significant impact in esthetic and functional outcomes of implant-supported restorations. Computer-assisted template-based implant placement (guided surgery) have become increasingly popular due to improved planning and the higher transfer accuracy of the virtual plan to the surgical site compared with freehand insertion or freehand final drilling. Digital impressions replace the need for traditional materials that can be inconvenient and messy for patients. To the best of our knowledge, at the time of planning this study, there were no published RCTs evaluating a fully digital approach for computer-assisted template-based implant placement. The aim of the present study is to compare early implant failure, template-related complications, and virtual planning accuracy of computer-assisted template-based implant placement using conventional impression and scan model or digital impression. The null hypothesis is that there will be no difference between these interventions.

NCT ID: NCT03762330 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Structured Comprehensive Intervention to Stimulate Self- Management and Improve Quality of Life in COPD Patients

Start date: January 19, 2019
Phase: N/A
Study type: Interventional

This study evaluates the effect of of a structured self-management intervention plan in patients with chronic obstructive pulmonary disease in primary care setting.Half of the participants will receive the self-management plan while the other half will receive usual care.

NCT ID: NCT03761108 Recruiting - Multiple Myeloma Clinical Trials

Phase 1/2 Study of REGN5458 in Adult Patients With Relapsed or Refractory Multiple Myeloma

LINKER-MM1
Start date: January 23, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The main purpose of this study is to learn about the safety of REGN5458 and to find out what is the best dose of REGN5458 to give to patients with multiple myeloma. An additional purpose is to look for any signs that REGN5458 can treat cancer. The study is looking at several other research questions, including: - Side effects that may be experienced by people receiving REGN5458 - How REGN5458 works in the body - How much REGN5458 is present in the blood - How REGN5458 may work to treat cancer

NCT ID: NCT03759678 Recruiting - Clinical trials for Ataxia Telangiectasia

N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T)

Start date: January 8, 2020
Phase: Phase 2
Study type: Interventional

This is a multinational, multicenter, open-label, rater-blinded prospective Phase II study which will assess the safety and efficacy of N-Acetyl-L-Leucine (IB1001) for the treatment of Ataxia-Telangiectasia (A-T). There are two phases to this study: the Parent Study, and the Extension Phase. The Parent Study evaluates the safety and efficacy of N-Acetyl-L-Leucine (IB1001) for the symptomatic treatment of A-T. The Extension Phase evaluates the long-term safety and efficacy of IB1001 for the neuroprotective, disease-modifying treatment of A-T.

NCT ID: NCT03749837 Recruiting - Intubation Clinical Trials

C-MAC Video Stylet vs. Video Endoscope

Start date: December 15, 2018
Phase: N/A
Study type: Interventional

The purpose of the study is to compare first attempt success rates and time until intubation to establish the learning curves of the participating anaesthesiologists with two different intubation strategies: (Karl Storz C-MAC VS (Video Stylet) and the standard flexible intubation video endoscope at the study site.

NCT ID: NCT03746938 Recruiting - Clinical trials for Heart Failure With Reduced Ejection Fraction

First in Humans to Evaluate Collagen Patches With Stem Cells in Patients With Ischemic Left Ventricular Dysfunction

CARDIOMESH
Start date: November 13, 2018
Phase: Phase 1
Study type: Interventional

It´s a first open-label trial in humans to evaluate the safety and efficacy of epicardial delivery of collagen patches with adipose-derived stem cells in patients with ischemic heart disease and left ventricular dysfunction that remain symptomatic despite optimal medical treatment.

NCT ID: NCT03745911 Recruiting - Clinical trials for Metastatic Urothelial Cancer

Paclitaxel and TAK-228 in Urothelial Carcinoma

Start date: May 4, 2018
Phase: Phase 2
Study type: Interventional

Phase II Multicentre, single arm, open label study of Paclitaxel and TAK-228 in metastatic urothelial carcinoma (UC) and the impact of PI3K-mTOR pathway genomic alterations